Personalized Cancer Medicine: Are We There Yet?

A primary aim of pharmacogenomics is to devise personalized treatment strategies based on an individual’s genetic makeup to maximize the potential for therapeutic benefit and minimize the risk of adverse side effects. Dr. Dolan will discuss the role of pharmacogenomics in cancer research, a field in which personalized drug therapy is especially desirable given the narrow therapeutic index and life-threatening consequences of drug toxicity.